Molecular diagnostics are specialized tests doctors use to look at proteins, RNA, and DNA in and on cancer cells. When you have breast cancer, they show your doctors what’s unique about your tumor so ...

Molecular diagnostics hold immense potential, but their precision depends on rigorous quality control, validation, and verification processes. From assay design to data management, every step impacts ...

The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert ® MTB/RIF Ultra. It is the first test for TB diagnosis and ...

A clinical trial conducted in Tanzania and Mozambique and published in The Lancet Infectious Diseases concludes that expanding the use of molecular diagnostic tests on urine and stool samples, in ...

Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...

Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...

Over the past few months, the Molecular Diagnostics market has been prospering well on the back of the COVID-19 havoc, followed by the surge in Monkeypox cases. Apart from these instances, the niche ...

The MiniDock MTB could expand access to molecular testing in peripheral health centers ...

Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, today announced the United States Patent and Trademark Office has issued U.S. Patent No.